ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high

$13.26

Daily low

$13.10

Price at open

$13.22

52 Week High

$17.35

52 Week Low

$9.46

Market cap

23.5B

Dividend yield

3.77%

Volume

182,453

Avg. volume

211,643

P/E ratio

12.13

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News